Why Pfizer and other blue-chip brands are building internal AI search hubs to reclaim control

The ad industry’s latest dernier cri is going in-house. Marketers at major advertisers, such as Pfizer, are pulling generative engine optimization (GEO) expertise inside the tent as their sense of urgency over search’s shifting landscape grows.

Pfizer officially transitioned its SEO and AI discoverability efforts to its in-house team this week, according to a LinkedIn post from Joshua Palau, the firm’s vp of performance media. It took about 60 days to build out the capability, complete with new hires, including Kinesso’s former director of SEO, per the post. 

‘We have more experience’

Pfizer isn’t the only advertiser making SEO and AI search expertise an internal matter. Georgia Pacific and U.S. Bank have both stood up teams within their internal marketing units recently, while Adobe, Hertz, T-Mobile, Lowe’s and Skims are all currently advertising for managerial or directorial positions that include responsibility for SEO and AI discoverability. 

Continue reading this article on digiday.com. Sign up for Digiday newsletters to get the latest on media, marketing and the future of TV.

,Read More

Future of Marketing Briefing: The ad industry has an AI label problem

People no longer trust what they see, and the ad industry hasn’t agreed on what honesty looks like in response.

Does an AI-generated background warrant a label? What about a synthesized soundtrack? Or does the threshold only kick in when it’s a human face, a product claim or a body that never existed? These feel like mundane distinctions until you factor in what labelling actually costs. Research from NYU Stern and Emory University suggest that AI disclosure can reduce ad effectiveness by up to 31.5%. 

This is a member-exclusive article from Digiday. Continue reading it on digiday.com and subscribe to continue reading content like this.

,Read More